MASCT by Hengrui Yuanzheng Biotechnology for Soft Tissue Sarcoma: Likelihood of Approval

MASCT is under clinical development by Hengrui Yuanzheng Biotechnology and currently in Phase I for Soft Tissue Sarcoma.

Canadian Cannabis Sales Increased In April

Statistics Canada released April retail sales for the country, with cannabis sales increasing from the March levels, up 5.3% to C$428.6 million. On a per-day basis, sales

June 21, 2024

Antioxidant-rich diet could help lower risk of infertility in women, new study suggests

The study reveals that increased antioxidant consumption may protect against infertility in women, addressing oxidative stress in reproductive disorders.

October 3, 2024

Chemo Shortage: ‘Paycheck to Paycheck’; Cancer Blood Test Shines; Struggling to Live

The shortage of crucial cancer drugs has eased a bit, but the vast majority of cancer centers are still “living paycheck to paycheck.” (STAT) Final

October 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.